← Back to Analyst Consensus 
ACH Hold
ACCENDRA HEALTH INC/VA/
Current Price —
Implied Upside —
Analysts 12
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Next Earnings
Nov 5, 2026 (10 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Aug 13, 2026 | UBS | maintain | Neutral → Neutral | — | 54% |
| Aug 11, 2026 | Citigroup | downgrade | Buy → Neutral | — | 54% |
| Jul 24, 2026 | Citigroup | maintain | Buy → Buy | — | 54% |
| May 12, 2026 | UBS | maintain | Neutral → Neutral | — | 54% |
| May 12, 2026 | Citigroup | maintain | Buy → Buy | — | 54% |
| May 12, 2026 | Baird | maintain | Outperform → Outperform | — | 55% |
| Feb 20, 2026 | Leerink Partners | maintain | Market Perform → Market Perform | $2.75 | 51% |
| Jan 9, 2026 | Citigroup | maintain | Buy → Buy | $4 | 54% |
| Nov 3, 2025 | UBS | downgrade | Buy → Neutral | $4 | 54% |
| Aug 27, 2025 | JP Morgan | maintain | Underweight → Underweight | $6 | 54% |
| Aug 13, 2025 | UBS | maintain | Buy → Buy | $7 | 54% |
| Aug 12, 2025 | Baird | maintain | Outperform → Outperform | $7 | 55% |
| Aug 12, 2025 | Citigroup | maintain | Buy → Buy | $7 | 54% |
| Aug 12, 2025 | B of A Securities | maintain | Underperform → Underperform | $4.75 | 53% |
Price Target Trend
Apr 2, 2026 Oct 26, 2026
EPS Estimates
0y —
+1q —
+1y —
0q —
Cross-Platform Signals
No cross-platform signals in the last 90 days